You are here: Industry Insights > hydroxychloroquine

News List

Lincoln Pharma gets approval to manufacture hydroxychloroquine expresspharma
April 28, 2020
After necessary approval from the DGFT, the company will be able to export these products.
FDA COVID-19 Update contractpharma
April 28, 2020
FDA issues a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine.
FDA Cautions Use of Hydroxychloroquine, Chloroquine for COVID-19 Outside Hospital Due americanpharmaceuticalrevie
April 26, 2020
The FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and other QT prolonging medicines. We are also aware of increased use of these me
EMA warns about side effects of chloroquine and hydroxychloroquine for COVID-19 treatment europeanpharmaceuticalreview
April 24, 2020
The COVID-19 European Medicines Agency (EMA) pandemic Task Force (COVID-ETF) warned that chloroquine and hydroxychloroquine are yet to be proved effective at treating COVID-19 and that their side effects could be fatal.
NIH panel warns against use of hydroxychloroquine to treat Covid-19 pharmaceutical-technology
April 23, 2020
A US National Institutes of Health (NIH) panel has recommended against the use of hydroxychloroquine in combination with azithromycin as a Covid-19 treatment.
Hydroxychloroquine for coronavirus shows no benefit, possible harm in study awaiting validation expresspharma
April 23, 2020
An analysis of Veterans Health Administration (VA) data found that 28 per cent of 97 patients given hydroxychloroquine along with standard care died, compared with a death rate of 11 per cent for the 158 patients that did not receive the drug.
Indian pharmaceutical firms will play important role in fight against COVID19 pandemic: Ambassador Taranjit Singh Sandhu expresspharma
April 23, 2020
India, one of the largest producers of anti-malarial drug hydroxychloroquine, has seen a spurt in demand in recent weeks. India has sent the drug to over 50 countries over the last few days, including the United States, he said.
Novartis to test efficacy of old malaria drug against COVID-19 expresspharma
April 22, 2020
The company hopes to have data on its efficacy by June, a lead researcher for the trial told Reuters.
Novartis to Sponsor Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients americanpharmaceuticalreview
April 21, 2020
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19
A dive into COVID-19 treatment avenues expresspharma
April 16, 2020
“Frost & Sullivan’s analysis reveals that hydroxychloroquine and Remdesivir are likely to emerge as important treatment strategies for COVID-19,” ...

Previous page 1 2 3 4 5 6 Next page